葡萄糖酸钙氯化钠注射液与葡萄糖酸钙注射液所致不良反应的临床观察  

Clinical observation of adverse reactions caused by calcium gluconate sodium chloride injection and calcium gluconate injection

在线阅读下载全文

作  者:马小兵 Ma Xiaobing(Department of Surgery,the People's Hospital of Dongxiang County,Jiangxi Province 331800)

机构地区:[1]江西省东乡县人民医院外科,331800

出  处:《中国社区医师》2016年第28期13-14,共2页Chinese Community Doctors

摘  要:目的:评价葡萄糖酸钙氯化钠注射液与葡萄糖酸钙注射液所致不良反应与注射时间。方法:收治采用葡萄糖酸钙进行治疗的患者240例,平分为3组。A组将10mL的10%葡萄糖酸钙加入10mL的10%葡萄糖注射液中稀释,给予患者静脉推注,20min内注射完毕;B组将10mL的10%葡萄糖酸钙加入100mL的10%葡萄糖注射液中稀释,给予患者静脉滴注,25~35滴/min,时间≥30min;C组给予葡萄糖酸钙氯化钠注射液静脉滴注,25~35滴/min,时间≥30min。比较3组患者的不良反应发生率与输注时间。结果:C组不良反应发生率最低(P<0.05),与B组比较,C组注射时间显著减少(P<0.05)。结论:采用葡萄糖酸钙氯化钠注射液治疗不良反应更少,且输注时间也显著减少。Objective:To evaluate the adverse reactions and injection time caused by calcium gluconate sodium chloride injectionand calcium gluconate injection.Methods:240 patients treated by calcium glucose were selected.They were divided into 3 groups.The A group added 10 mL of 10% calcium gluconate to 10 mL 10% glucose injection for dilution,to give patients intravenousbolus,within 20 minutes of injection.The B group added 10 mL of 10% calcium gluconate to 10O mL 10% glucose injection fordilution,intravenously administered to patients,25~35 gtt/min,and time was more than 30 min.The C group was given intravenousinfusion of calcium gluconate and sodium chloride injection,25~35 gtt/min,and time was more than 30 min.The incidence ofadverse reactions and the time of infusion in the 3 groups were compared.Results:The incidence of adverse reactions in the groupC was the lowest(P<0.05);compared with the group B,the injection time of the group C was significantly lower(P<0.05).Conclusion:The adverse effects of calcium gluconate sodium chloride injection treatment were lower,and the infusion time wassignificantly lower.

关 键 词:葡萄糖酸钙氯化钠注射液 葡萄糖酸钙注射液 不良反应 

分 类 号:R977[医药卫生—药品]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象